(2S,3S,4R,5S,6S,8S,11R,12R,13S,14R,15S,16S,18E)-1-(8,15-bis(tert-butyldimethylsilyloxy)-13-triethylsilyloxy-11-methoxy-4-methoxybenzyl)oxy-2,4,6,12,14,16,18-heptamethyl-3,5-[(dimethyl-methylene)dioxy]-icos-18-en-9-one | 1447732-04-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2S,3S,4R,5S,6S,8S,11R,12R,13S,14R,15S,16S,18E)-1-(8,15-bis(tert-butyldimethylsilyloxy)-13-triethylsilyloxy-11-methoxy-4-methoxybenzyl)oxy-2,4,6,12,14,16,18-heptamethyl-3,5-[(dimethyl-methylene)dioxy]-icos-18-en-9-one
• 英文别名: (E,2S,4S,7R,8R,9S,10R,11S,12S)-4,11-bis[[tert-butyl(dimethyl)silyl]oxy]-7-hydroxy-2-[(4S,5R,6S)-6-[(2S)-1-[(4-methoxyphenyl)methoxy]propan-2-yl]-2,2,5-trimethyl-1,3-dioxan-4-yl]-8,10,12,14-tetramethyl-9-triethylsilyloxyhexadec-14-en-5-one
• CAS: 1447732-04-8
• 化学式: C₅₆H₁₀₆O₉Si₃
• 分子量: 1007.71
• InChiKey: UOGLKSJYNHVZFT-IJBLVNTRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  14.79
• 重原子数：
  68
• 可旋转键数：
  30
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.84
• 拓扑面积：
  102
• 氢给体数：
  1
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  (2S,3S,4R,5S,6S,8S,11R,12R,13S,14R,15S,16S,18E)-1-(8,15-bis(tert-butyldimethylsilyloxy)-13-triethylsilyloxy-11-methoxy-4-methoxybenzyl)oxy-2,4,6,12,14,16,18-heptamethyl-3,5-[(dimethyl-methylene)dioxy]-icos-18-en-9-one 在 吡啶 、 水 、 1,8-双二甲氨基萘 、 氟化氢吡啶 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 121.0h， 生成
  参考文献：
  名称：

  Stereoselective synthesis of the C13–32 spiroacetal fragment of spirangien A

  摘要：

  Stereoselective synthesis of an advanced intermediate towards the highly cytotoxic polyketide metabolite spirangien A was achieved. A key step in the synthesis was installation of the C23 stereocentre by a substrate controlled C22-23 aldol reaction. Comparison of this result with previous literature reports suggests that the facial preference of the aldehyde controls the outcome of the C22-23 aldol coupling and depends on the 027/25 protecting groups when reacting with complex ketones, which contain the C17-15 stereochemistry. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2013.06.012
• 作为产物：
  描述：

  (3S,5S,6S,7R,9S)-3-(tert-butyldimethylsilyloxy)-6,8-dihydroxy-10-(4-methoxyphenyl)oxy-5,7,9-trimethyl-dec-1-yne 在 mercury(II) diacetate 、 4-甲基苯磺酸吡啶 、 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 17.0h， 生成 (2S,3S,4R,5S,6S,8S,11R,12R,13S,14R,15S,16S,18E)-1-(8,15-bis(tert-butyldimethylsilyloxy)-13-triethylsilyloxy-11-methoxy-4-methoxybenzyl)oxy-2,4,6,12,14,16,18-heptamethyl-3,5-[(dimethyl-methylene)dioxy]-icos-18-en-9-one
  参考文献：
  名称：

  Stereoselective synthesis of the C13–32 spiroacetal fragment of spirangien A

  摘要：

  Stereoselective synthesis of an advanced intermediate towards the highly cytotoxic polyketide metabolite spirangien A was achieved. A key step in the synthesis was installation of the C23 stereocentre by a substrate controlled C22-23 aldol reaction. Comparison of this result with previous literature reports suggests that the facial preference of the aldehyde controls the outcome of the C22-23 aldol coupling and depends on the 027/25 protecting groups when reacting with complex ketones, which contain the C17-15 stereochemistry. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2013.06.012

文献信息

• Stereoselective synthesis of the C13–32 spiroacetal fragment of spirangien A
  作者：Claire Gregg、Michael V. Perkins

  DOI：10.1016/j.tet.2013.06.012

  日期：2013.8

  Stereoselective synthesis of an advanced intermediate towards the highly cytotoxic polyketide metabolite spirangien A was achieved. A key step in the synthesis was installation of the C23 stereocentre by a substrate controlled C22-23 aldol reaction. Comparison of this result with previous literature reports suggests that the facial preference of the aldehyde controls the outcome of the C22-23 aldol coupling and depends on the 027/25 protecting groups when reacting with complex ketones, which contain the C17-15 stereochemistry. (C) 2013 Elsevier Ltd. All rights reserved.